AZA plus Glutaminase Inhibition with Telaglenastat (CB-839) for Advanced MDS: An Updated Interim Analysis

Saxena, K; Konopleva, M; Bhagat, TD; Guerra, VA; Maduike, R; Tiziani, S; Borthakur, G; Jabbour, E; Pemmaraju, N; Kadia, TM; Short, NJ; Burger, JA; Kornblau, SM; Daver, N; Naqvi, K; Cai, TY; Kuruvilla, VM; Kantarjian, HM; Garcia-Manero, G; Verma, A; DiNardo, CD

BLOOD, 2020; 136 ():